BOULDER, Colo.–(BUSINESS WIRE)—- $BDSX #patientsfirst–Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, announced today that the Company was named the leading Proteomics Solutions Company in the U.S. by Life Sciences Review Magazine, featured in the December 2022 issue, “Top 10 Proteomics Solutions Companies of 2022.” Biodesix is a market leader with over 15 years of experience in the field of clinical proteomics. The Company’s expertise focuses on profi
Click here to view original post
News
Imperative Care Announces Clinical Data from the Pivotal Imperative Trial Evaluating the Zoom Reperfusion System for the Treatment of Ischemic Stroke
CAMPBELL, Calif.–(BUSINESS WIRE)–Imperative Care, Inc. announces late-breaking data from the Imperative Trial at the SNIS 2024 21st Annual Meeting in Colorado Springs. Click here to view original post Click Here to Publish/Feature Your Company or […]
News
Colorado’s Life Sciences Ecosystem Raised $3.2 Billion in 2025
Acquisitions of Paragon 28 and Foresight Diagnostics Contribute to Fundraising Record For Immediate Release: January 12, 2026 DENVER – Colorado BioScience Association (CBSA) announces the state’s life sciences ecosystem raised $3.2 billion in 2025, a […]
News
Can AI Cause Psychosis?
AI platforms have been at the center of several high-profile psychosis cases – even among people without a history of mental health conditions. Click here to view original post Click Here to Publish/Feature Your Company […]
